Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
Bulletin of Mathematical Biology|April 3, 2002
Modeling deuterated glucose labeling of T-lymphocytesRuy M Ribeiro, Hiroshi Mohri, David D Ho, et al.
Emerging Microbes & Infections|June 25, 2020
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodiesChasity D Andrews, Yaoxing Huang, David D Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2002
In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?Ruy M Ribeiro, Hiroshi Mohri, David D Ho, et al.
Current Protocols in Immunology|April 25, 2008
Isolation and quantitation of HIV in peripheral bloodRichard A Koup, David D Ho, Guido Poli, et al.
Science (New York, N.Y.)|January 24, 2004
Retraction of an interpretationLinqi Zhang, Peter Lopez, Tian He, et al.
Antiviral Therapy|May 12, 2004
Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapyNarendra M Dixit, Martin Markowitz, David D Ho, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Angiotensin converting enzyme 2 is a novel target of the γ-secretase complexAlberto Bartolomé, Jiani Liang, Pengfei Wang, et al.
Scientific Reports|May 8, 2021
Angiotensin converting enzyme 2 is a novel target of the γ-secretase complexAlberto Bartolomé, Jiani Liang, Pengfei Wang, et al.
Proceedings. Biological Sciences|May 10, 2003
Estimating average cellular turnover from 5-bromo-2'-deoxyuridine (BrdU) measurementsRob J De Boer, Hiroshi Mohri, David D Ho, et al.
Vaccine|May 26, 2009
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin ADavid F Gardiner, Talia Rosenberg, Jerry Zaharatos, et al.
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
Bulletin of Mathematical Biology|April 3, 2002
Modeling deuterated glucose labeling of T-lymphocytesRuy M Ribeiro, Hiroshi Mohri, David D Ho, et al.
Emerging Microbes & Infections|June 25, 2020
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodiesChasity D Andrews, Yaoxing Huang, David D Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2002
In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?Ruy M Ribeiro, Hiroshi Mohri, David D Ho, et al.
Current Protocols in Immunology|April 25, 2008
Isolation and quantitation of HIV in peripheral bloodRichard A Koup, David D Ho, Guido Poli, et al.
Science (New York, N.Y.)|January 24, 2004
Retraction of an interpretationLinqi Zhang, Peter Lopez, Tian He, et al.
Antiviral Therapy|May 12, 2004
Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapyNarendra M Dixit, Martin Markowitz, David D Ho, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Angiotensin converting enzyme 2 is a novel target of the γ-secretase complexAlberto Bartolomé, Jiani Liang, Pengfei Wang, et al.
Scientific Reports|May 8, 2021
Angiotensin converting enzyme 2 is a novel target of the γ-secretase complexAlberto Bartolomé, Jiani Liang, Pengfei Wang, et al.
Proceedings. Biological Sciences|May 10, 2003
Estimating average cellular turnover from 5-bromo-2'-deoxyuridine (BrdU) measurementsRob J De Boer, Hiroshi Mohri, David D Ho, et al.
Vaccine|May 26, 2009
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin ADavid F Gardiner, Talia Rosenberg, Jerry Zaharatos, et al.
Pageof 25